Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
28567 | 204 | 25.0 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
320 | 3 | AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//MEDICATION ERRORS//AMERICAN JOURNAL OF HOSPITAL PHARMACY | 39312 |
2978 | 2 | PHARMACOVIGILANCE//ADVERSE DRUG REACTIONS//DRUG SAFETY | 2605 |
28567 | 1 | CODISPENSING//RISK EVALUATION AND MITIGATION STRATEGIES//BOXED WARNINGS | 204 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CODISPENSING | authKW | 336786 | 1% | 75% | 3 |
2 | RISK EVALUATION AND MITIGATION STRATEGIES | authKW | 311835 | 2% | 42% | 5 |
3 | BOXED WARNINGS | authKW | 299367 | 1% | 100% | 2 |
4 | DEAR DOCTOR | authKW | 299367 | 1% | 100% | 2 |
5 | DEAR DOCTOR LETTERS | authKW | 299367 | 1% | 100% | 2 |
6 | DRUG LABEL CHANGE | authKW | 299367 | 1% | 100% | 2 |
7 | DRUG SAFETY OVERSIGHT BOARD | address | 299367 | 1% | 100% | 2 |
8 | LABORATORY MONITORING | authKW | 233146 | 4% | 17% | 9 |
9 | ADVERSE DRUG EVENTS QT INTERVAL | authKW | 149683 | 0% | 100% | 1 |
10 | BLANCHE IRWIN LERNER STUDY PHARMACEUT MANAG | address | 149683 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1693 | 53% | 0% | 108 |
2 | Health Care Sciences & Services | 1500 | 19% | 0% | 38 |
3 | Public, Environmental & Occupational Health | 917 | 28% | 0% | 57 |
4 | Health Policy & Services | 695 | 10% | 0% | 20 |
5 | Medical Informatics | 610 | 7% | 0% | 14 |
6 | Medicine, General & Internal | 229 | 17% | 0% | 34 |
7 | Toxicology | 191 | 10% | 0% | 20 |
8 | Medical Laboratory Technology | 101 | 4% | 0% | 8 |
9 | Information Science & Library Science | 24 | 2% | 0% | 4 |
10 | Primary Health Care | 16 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG SAFETY OVERSIGHT BOARD | 299367 | 1% | 100% | 2 |
2 | BLANCHE IRWIN LERNER STUDY PHARMACEUT MANAG | 149683 | 0% | 100% | 1 |
3 | CLIN PHARMACOLPHARMACOEPIDEMIOL PROGRAM | 149683 | 0% | 100% | 1 |
4 | DIS DECIS SUPPORT GRP | 149683 | 0% | 100% | 1 |
5 | DRUG SAFETY I3 | 149683 | 0% | 100% | 1 |
6 | ECREENING TEST EVALUAT PROGRAM | 149683 | 0% | 100% | 1 |
7 | EPIDEMIOL DRUG SAFETY SURVEILLANCE | 149683 | 0% | 100% | 1 |
8 | FALLON FDN FALLON COMMUNITY HLTH PLAN | 149683 | 0% | 100% | 1 |
9 | FARM GRANADA | 149683 | 0% | 100% | 1 |
10 | INTERDISCIPLINARY WOMENS HLTHSEALY A | 149683 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 47266 | 13% | 1% | 27 |
2 | HOSPITAL PHARMACY | 21382 | 0% | 14% | 1 |
3 | DRUG SAFETY | 20734 | 8% | 1% | 17 |
4 | THERAPEUTIC INNOVATION & REGULATORY SCIENCE | 10299 | 2% | 1% | 5 |
5 | JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION | 2916 | 2% | 0% | 4 |
6 | AMERICAN JOURNAL OF MANAGED CARE | 2688 | 3% | 0% | 7 |
7 | AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2020 | 3% | 0% | 7 |
8 | POPULATION HEALTH MANAGEMENT | 1456 | 1% | 0% | 2 |
9 | DRUG INFORMATION JOURNAL | 1222 | 1% | 0% | 3 |
10 | RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY | 1186 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CODISPENSING | 336786 | 1% | 75% | 3 | Search CODISPENSING | Search CODISPENSING |
2 | RISK EVALUATION AND MITIGATION STRATEGIES | 311835 | 2% | 42% | 5 | Search RISK+EVALUATION+AND+MITIGATION+STRATEGIES | Search RISK+EVALUATION+AND+MITIGATION+STRATEGIES |
3 | BOXED WARNINGS | 299367 | 1% | 100% | 2 | Search BOXED+WARNINGS | Search BOXED+WARNINGS |
4 | DEAR DOCTOR | 299367 | 1% | 100% | 2 | Search DEAR+DOCTOR | Search DEAR+DOCTOR |
5 | DEAR DOCTOR LETTERS | 299367 | 1% | 100% | 2 | Search DEAR+DOCTOR+LETTERS | Search DEAR+DOCTOR+LETTERS |
6 | DRUG LABEL CHANGE | 299367 | 1% | 100% | 2 | Search DRUG+LABEL+CHANGE | Search DRUG+LABEL+CHANGE |
7 | LABORATORY MONITORING | 233146 | 4% | 17% | 9 | Search LABORATORY+MONITORING | Search LABORATORY+MONITORING |
8 | ADVERSE DRUG EVENTS QT INTERVAL | 149683 | 0% | 100% | 1 | Search ADVERSE+DRUG+EVENTS+QT+INTERVAL | Search ADVERSE+DRUG+EVENTS+QT+INTERVAL |
9 | CANCER RISK WITH BECAPLERMIN | 149683 | 0% | 100% | 1 | Search CANCER+RISK+WITH+BECAPLERMIN | Search CANCER+RISK+WITH+BECAPLERMIN |
10 | CLINICAL PHARMACIST TEAMS | 149683 | 0% | 100% | 1 | Search CLINICAL+PHARMACIST+TEAMS | Search CLINICAL+PHARMACIST+TEAMS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MCDOWELLL, SE , FERNER, RE , (2011) BIOCHEMICAL MONITORING OF PATIENTS TREATED WITH ANTIHYPERTENSIVE THERAPY FOR ADVERSE DRUG REACTIONS A SYSTEMATIC REVIEW.DRUG SAFETY. VOL. 34. ISSUE 11. P. 1049-1059 | 19 | 51% | 4 |
2 | SANFELIX-GIMENO, G , CERVERA-CASINO, P , PEIRO, S , LOPEZ-VALCARCEL, BG , BLAZQUEZ, A , BARBERA, T , (2009) EFFECTIVENESS OF SAFETY WARNINGS IN ATYPICAL ANTIPSYCHOTIC DRUGS AN INTERRUPTED TIME-SERIES ANALYSIS IN SPAIN.DRUG SAFETY. VOL. 32. ISSUE 11. P. 1075 -1087 | 17 | 55% | 11 |
3 | MACIEJEWSKI, ML , HAMMILL, BG , QUALLS, LG , HASTINGS, SN , WANG, V , CURTIS, LH , (2016) APPROPRIATE BASELINE LABORATORY TESTING FOLLOWING ACEI OR ARB INITIATION BY MEDICARE FFS BENEFICIARIES.PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. VOL. 25. ISSUE 9. P. 1015 -1022 | 13 | 57% | 0 |
4 | CHENG, CM , DELIZZA, C , KAPUSNIK-UNER, J , (2014) PREVALENCE AND THERAPEUTIC CLASSIFICATIONS OF FDA-APPROVED PRESCRIPTION DRUGS WITH BOXED WARNINGS.THERAPEUTIC INNOVATION & REGULATORY SCIENCE. VOL. 48. ISSUE 2. P. 165-172 | 6 | 100% | 1 |
5 | THEOPHILE, H , MIREMONT-SALAME, G , ROBINSON, P , MOORE, N , BEGAUD, B , HARAMBURU, F , (2011) RELEVANCE OF A "DEAR DOCTOR LETTER" TO ALERT HEALTHCARE PROVIDERS TO NEW RECOMMENDATIONS FOR VITAMIN D ADMINISTRATION.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 67. ISSUE 7. P. 681-686 | 11 | 58% | 2 |
6 | HOFFMAN, KB , DEMAKAS, AR , DIMBIL, M , TATONETTI, NP , ERDMAN, CB , (2014) STIMULATED REPORTING: THE IMPACT OF US FOOD AND DRUG ADMINISTRATION-ISSUED ALERTS ON THE ADVERSE EVENT REPORTING SYSTEM (FAERS).DRUG SAFETY. VOL. 37. ISSUE 11. P. 971 -980 | 18 | 32% | 5 |
7 | RODRIGUEZ-MONGUIO, R , SPIELBERGER, K , SEOANE-VAZQUEZ, E , (2014) EXAMINATION OF RISK EVALUATION AND MITIGATION STRATEGIES AND DRUG SAFETY IN THE US.RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY. VOL. 10. ISSUE 1. P. 232-238 | 7 | 78% | 1 |
8 | WINTERFIELD, L , VLEUGELS, RA , PARK, KK , (2015) THE VALUE OF THE BLACK BOX WARNING IN DERMATOLOGY.JOURNAL OF DRUGS IN DERMATOLOGY. VOL. 14. ISSUE 7. P. 12 -18 | 10 | 50% | 0 |
9 | MURTAZA, G , KHAN, SA , MURTAZA, G , JAVED, K , AKRAM, F , HAMID, AA , HUSSAIN, I , (2014) AN ASSESSMENT OF PAKISTANI PHARMACY AND MEDICAL STUDENTS' KNOWLEDGE OF BLACK BOX WARNINGS.ACTA BIOETHICA. VOL. 20. ISSUE 1. P. 119 -124 | 7 | 70% | 0 |
10 | GOLDMAN, RE , SORAN, CS , HAYWARD, GL , SIMON, SR , (2010) DOCTORS' PERCEPTIONS OF LABORATORY MONITORING IN OFFICE PRACTICE.JOURNAL OF EVALUATION IN CLINICAL PRACTICE. VOL. 16. ISSUE 6. P. 1136 -1141 | 10 | 53% | 7 |
Classes with closest relation at Level 1 |